Vivos Inc (RDGL)

[bdvest]

Gel technology offers a promising approach toward cancer treatment
Fist in aminals then in Humans

https://energyenvironment.pnnl.gov/highlights/highlight.asp?id=518
Do your DD, this is about PNNL

Results:
radiogel technology
In this CT scan-derived image, the radiogel is the solid mass, holding yttrium-90 particles in place within the tumor.An injectable radiogel technology developed by PNNL delivers the yttrium-90 medical isotope to a precise location in the body for targeted radiation therapy, while minimizing exposure to surrounding healthy tissue. Since 2010, PNNL has been working with publicly-held Advanced Medical Isotope Corporation (AMIC) of Kennewick, Wash., to move radiogels toward commercial application.

Why it Matters:
Safe, effective and relatively low-cost cancer treatments are needed for solid tumors that can’t be surgically removed. Yttrium-90 delivers a high energy beta particle with minimal damage to healthy tissues and decays quickly with a three day half-life.